← Back to contracts

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

US · MD · Bethesda National Institutes of Health (NIH) grant open #PAR-25-104
Response due Oct 25, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is offering a funding opportunity under the R34 mechanism to support planning activities for cancer prevention and control clinical trials. The program is designed to help researchers develop the infrastructure, protocols, and preliminary data needed to conduct future clinical trials in cancer prevention and control. This is a grant opportunity posted on Grants.gov, open for applications over a multi-year window from late 2024 through late 2027. The "Clinical Trials Optional" designation indicates applicants may or may not include a clinical trial component in their planning activities.

What they want

Funding is provided under the R34 grant mechanism to support planning and development activities for cancer prevention and control clinical trials. Awardees are expected to use grant funds to: design and refine clinical trial protocols; develop study infrastructure; conduct feasibility assessments; generate preliminary data; and otherwise prepare for a future full-scale clinical trial in cancer prevention and/or control. Clinical trial inclusion is optional — applicants may propose planning activities that do or do not involve a clinical trial component.
Deliverables
  • Clinical trial protocol development
  • Feasibility assessment reports
  • Study infrastructure development plan
  • Preliminary data collection and analysis
  • Planning documentation for future full-scale clinical trial

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

  • Extremely long open window (nearly 3 years) with rolling deadlines — specific internal due dates and review cycles not captured in this synopsis, which limits competitive planning
  • Minimal scope detail in the posted synopsis — full program requirements require review of the full PAR-25-104 announcement on NIH's grants portal

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541712
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Cancer Prevention and Control Clinical Tri…
Due Oct 25
Onboard ↗